MedPath

Schülke & Mayr GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

13

Active:9
Completed:3

Trial Phases

4 Phases

Phase 1:4
Phase 2:1
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
4 (50.0%)
Phase 3
2 (25.0%)
Phase 2
1 (12.5%)
Phase 4
1 (12.5%)

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Phase 3
Completed
Conditions
Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)
Interventions
Drug: Octenidinedihydrochlorid
Other: Placebo
First Posted Date
2017-12-19
Last Posted Date
2018-11-06
Lead Sponsor
Schülke & Mayr GmbH
Target Recruit Count
114
Registration Number
NCT03378401
Locations
🇦🇹

Universitätszahnklinik Wien, Fachbereich Zahnerhaltung und Parodontologie, Wien, Austria

🇩🇪

Poliklinik für Zahnerhaltung und Parodontologie des Universitätsklinikums Würzburg, Würzburg, Bavaria, Germany

🇩🇪

Poliklinik für Zahnerhaltung und Parodontologie der Universitätsklinik Köln, Köln, North Rhine-Westphalia, Germany

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Phase 3
Completed
Conditions
Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)
Interventions
Drug: Octenidinedihydrochlorid
Other: Placebo
First Posted Date
2017-10-26
Last Posted Date
2019-01-22
Lead Sponsor
Schülke & Mayr GmbH
Target Recruit Count
100
Registration Number
NCT03322124
Locations
🇩🇪

Poliklinik für Parodontologie der Johann Wolfgang Goethe Universität Frankfurt am Main, Frankfurt am Main, Hesse, Germany

🇩🇪

Poliklinik für Parodontologie der Med. Fakultät C. G. Carus der TU Dresden, Dresden, Saxony, Germany

🇩🇪

Poliklinik für Zahnerhaltung und Parodontologie am Universitätsklinikum Leipzig, Leipzig, Saxony, Germany

Dose Finding Study to Assess Octenidine Mouthwash Concentrations in Comparison to Placebo

Phase 2
Completed
Conditions
Gingivitis
Interventions
First Posted Date
2014-05-14
Last Posted Date
2014-05-14
Lead Sponsor
Schülke & Mayr GmbH
Target Recruit Count
90
Registration Number
NCT02138552
Locations
🇩🇪

Poliklinik für Parodontologie Med. Fakultät C. G. Carus der TU Dresden, Dresden, Germany

🇩🇪

Abteilung für Parodontologie in der Poliklinik für Zahnerhaltung und Parodontologie der Universität Würzburg, Würzburg, Germany

Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds

Phase 4
Terminated
Conditions
Ulcus Cruris
Interventions
Drug: Placebo
Drug: octenisept®
First Posted Date
2011-09-15
Last Posted Date
2014-05-13
Lead Sponsor
Schülke & Mayr GmbH
Target Recruit Count
9
Registration Number
NCT01434914
Locations
🇩🇪

University Medical Center Hamburg-Eppendorf, Hamburg, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.